Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Illerhaus, Gerald and Farreri, Andres J. M. and Binder, Mascha and Borchmann, Peter and Hasenkamp, Justin and Stilgenbauer, Stephan and Roeth, Alexander and Webern, Thomas and Egerer, Gerlinde and Ernst, Thomas and Hertenstein, Bernd and Lenz, Georg and Kobbe, Guido and Brunnberg, Uta and Schmidt, Christian and Kneba, Michael and Dreyling, Martin and Moehle, Robert and Panse, Jens and Heinicke, Thomas and Schroll, Sebastian and Larsen, Thomas S. and Salwender, Hans and Naumann, Ralph and Hess, Georg and Thurner, Lorenz and Pukrop, Tobias and Keller, Ulrich and Blystadt, Anne Kirsti and Kroschinsky, Frank P. and Re, Francesca and Pulczynski, Elisa and Orsucci, Lorella and Pospiech, Lisa and Deckert, Martina and Ponzoni, Maurilio and Wendler, Julia and Valk, Elke and Calimeri, Teresa and Kasenda, Benjamin and Trepel, Martin and Fricker, Heidi and von Gottberg, Philipp and Burger, Elvira and Ihorst, Gabriele and Grishina, Olga and Hader, Claudia and Zucca, Emanuele and Finke, Juergen and Schorb, Elisabeth (2022) Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43). In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 05 Sep 2023 04:52
Last Modified: 05 Sep 2023 10:06
URI: https://pred.uni-regensburg.de/id/eprint/58817

Actions (login required)

View Item View Item